Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.98)
# 56
Out of 4,509 analysts
618
Total ratings
64%
Success rate
39.2%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Reiterated: Buy | $59 | $41.81 | +41.11% | 45 | Jul 13, 2026 | |
| GRCE Grace Therapeutics | Maintained: Buy | n/a | $2.43 | - | 19 | Jul 13, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintained: Buy | n/a | $10.92 | - | 34 | Jul 13, 2026 | |
| XERS Xeris Biopharma Holdings | Rated: Buy | $12 | $8.16 | +47.06% | 29 | Jul 8, 2026 | |
| BVS Bioventus | Reiterated: Buy | $16 | $12.07 | +32.56% | 27 | Jul 7, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | n/a | $4.08 | - | 44 | Jul 6, 2026 | |
| CVRX CVRx, Inc. | Maintained: Buy | n/a | $5.43 | - | 28 | Jul 6, 2026 | |
| WEST Westrock Coffee Company | Maintained: Buy | n/a | $7.43 | - | 1 | Jul 1, 2026 | |
| GUTS Fractyl Health | Initiated Coverage: Buy | $4 | $0.7617 | +425.14% | 1 | Jul 1, 2026 | |
| MAMA Mama's Creations | Maintained: Buy | n/a | $19.03 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.10 | - | 21 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.49 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.38 | - | 4 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $40.21 | - | 36 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $189 → $171 | $103.79 | +64.76% | 27 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.34 | - | 37 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.21 | - | 32 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.4081 | - | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.04 | - | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.88 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.23 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.87 | - | 27 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.75 | - | 33 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.25 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.1 | $1.10 | - | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $76.56 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $132.15 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $89.30 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.81 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $309.25 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.12 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.17 | - | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.02 | - | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.87 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.04 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.77 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $46.68 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $17.68 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $13.99 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.11 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.81 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.34 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $20.03 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $9.30 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $31.94 | n/a | 1 | May 3, 2023 |
Harrow
Jul 13, 2026
Reiterated: Buy
Price Target: $59
Current: $41.81
Upside: +41.11%
Grace Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: n/a
Current: $2.43
Upside: -
Phathom Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: n/a
Current: $10.92
Upside: -
Xeris Biopharma Holdings
Jul 8, 2026
Rated: Buy
Price Target: $12
Current: $8.16
Upside: +47.06%
Bioventus
Jul 7, 2026
Reiterated: Buy
Price Target: $16
Current: $12.07
Upside: +32.56%
MiMedx Group
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.08
Upside: -
CVRx, Inc.
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $5.43
Upside: -
Westrock Coffee Company
Jul 1, 2026
Maintained: Buy
Price Target: n/a
Current: $7.43
Upside: -
Fractyl Health
Jul 1, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.7617
Upside: +425.14%
Mama's Creations
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $19.03
Upside: -
Jun 26, 2026
Maintained: Buy
Price Target: n/a
Current: $8.10
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $7.49
Upside: -
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $8.38
Upside: -
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $40.21
Upside: -
Jun 3, 2026
Reiterated: Buy
Price Target: $189 → $171
Current: $103.79
Upside: +64.76%
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $37.34
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $4.21
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $0.4081
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $5.04
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.88
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $4.23
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $12.87
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $10.75
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: n/a
Current: $14.25
Upside: -
Mar 10, 2026
Rated: Buy
Price Target: $1.1
Current: $1.10
Upside: -
Nov 20, 2025
Maintained: Buy
Price Target: n/a
Current: $76.56
Upside: -
Nov 19, 2025
Maintained: Buy
Price Target: n/a
Current: $132.15
Upside: -
Oct 20, 2025
Maintained: Buy
Price Target: n/a
Current: $89.30
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $45.81
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: n/a
Current: $309.25
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $68.12
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $4.17
Upside: -
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $68.02
Upside: -
Jul 14, 2025
Maintained: Buy
Price Target: n/a
Current: $9.87
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $12
Current: $9.04
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $4.77
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $46.68
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $38
Current: $17.68
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $13.99
Upside: n/a
Mar 21, 2024
Maintained: Buy
Price Target: $10
Current: $2.11
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $5.81
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $2.34
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $20.03
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $9.30
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $31.94
Upside: n/a